OBJECTIVE: To evaluate functional improvement in a population of frail, homebound older persons with low vitamin D status as vitamin D stores improve. DESIGN: Randomized, controlled intervention study. SETTING:Subjects' homes and a nursing facility in Baltimore, Maryland. PARTICIPANTS: The first 32 subjects (community-dwelling, homeboundolder subjects from the Johns Hopkins Elder Housecall Program and nursing home residents from the Johns Hopkins Geriatrics Center) entered in a longitudinal study ofvitamin D replacement. MEASUREMENTS: Baseline 25-hydroxyvitamin D levels were measured and repeated at least 1 month after therapy with either placebo or vitamin D (ergocalciferol). Subjects were also administered the Frail Elderly Functional Assessment (FEFA) questionnaire, an instrument demonstrated to be reliable, valid, and sensitive to small increments of functional change in this population. MAIN RESULTS:All subjects started with 25-hydroxyvitamin D levels less than 15 ng/mL. Those subjects whose levels improved by at least 3 ng/mL (> assay coefficient of variation) also demonstrated improvement in FEFA score. Regression analysis between change in FEFA score compared with change in 25-hydroxyvitamin D was significant (r = .4; P = .02). CONCLUSIONS: In this cohort of homebound older people, improvement in vitamin D status was associated with functional improvement as measured by the FEFA questionnaire.
RCT Entities:
OBJECTIVE: To evaluate functional improvement in a population of frail, homebound older persons with low vitamin D status as vitamin D stores improve. DESIGN: Randomized, controlled intervention study. SETTING: Subjects' homes and a nursing facility in Baltimore, Maryland. PARTICIPANTS: The first 32 subjects (community-dwelling, homebound older subjects from the Johns Hopkins Elder Housecall Program and nursing home residents from the Johns Hopkins Geriatrics Center) entered in a longitudinal study of vitamin D replacement. MEASUREMENTS: Baseline 25-hydroxyvitamin D levels were measured and repeated at least 1 month after therapy with either placebo or vitamin D (ergocalciferol). Subjects were also administered the Frail Elderly Functional Assessment (FEFA) questionnaire, an instrument demonstrated to be reliable, valid, and sensitive to small increments of functional change in this population. MAIN RESULTS: All subjects started with 25-hydroxyvitamin D levels less than 15 ng/mL. Those subjects whose levels improved by at least 3 ng/mL (> assay coefficient of variation) also demonstrated improvement in FEFA score. Regression analysis between change in FEFA score compared with change in 25-hydroxyvitamin D was significant (r = .4; P = .02). CONCLUSIONS: In this cohort of homebound older people, improvement in vitamin D status was associated with functional improvement as measured by the FEFA questionnaire.
Authors: A Salva; L Coll-Planas; S Bruce; L De Groot; S Andrieu; G Abellan; B Vellas; Sandrine Andrieu; Luisa Bartorelli; Ytshal N Berner; Stuart Bruce; Bruno Corman; Alex Domingo; Thomas P Egger; Lisette de Groot; Yves Guigoz; Ana Imedio; Mercè Planas; Concha Porras; Joan Carles Rovira; Antoni Salvà; José Antonio Serra; Bruno Vellas Journal: J Nutr Health Aging Date: 2009-06 Impact factor: 4.075
Authors: Tyler Barker; Thomas B Martins; Harry R Hill; Carl R Kjeldsberg; Brian M Dixon; Erik D Schneider; Vanessa T Henriksen; Lindell K Weaver Journal: Eur J Appl Physiol Date: 2013-01-06 Impact factor: 3.078
Authors: H A Bischoff-Ferrari; M Conzelmann; H B Stähelin; W Dick; M G Carpenter; A L Adkin; R Theiler; M Pfeifer; J H J Allum Journal: Osteoporos Int Date: 2006-03-01 Impact factor: 4.507
Authors: Isabel Marantes; Sara J Achenbach; Elizabeth J Atkinson; Sundeep Khosla; L Joseph Melton; Shreyasee Amin Journal: J Bone Miner Res Date: 2011-12 Impact factor: 6.741